Literature DB >> 25592694

Lipoprotein-associated phospholipase A2 and aortic stenosis: biomarker or new target for an old foe?

Donald Heistad1, Hardik Doshi2.   

Abstract

Entities:  

Keywords:  Doppler echocardiography; aortic stenosis; calcific aortic valve disease; lipoprotein-associated phospholipase A2

Mesh：

Substances：

Year:  2015        PMID： 25592694      PMCID： PMC4297317          DOI： 10.1016/j.jcmg.2014.11.001

Source DB:  PubMed          Journal:  JACC Cardiovasc Imaging        ISSN： 1876-7591


× No keyword cloud information.
  10 in total

1.  Aortic valve calcium content does not predict aortic valve area.

Authors:  Emile R Mohler; Elizabeth Medenilla; Hao Wang; Craig Scott
Journal:  J Heart Valve Dis       Date:  2006-05

2.  Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.

Authors:  Robert L Wilensky; Yi Shi; Emile R Mohler; Damir Hamamdzic; Mark E Burgert; Jun Li; Anthony Postle; Robert S Fenning; James G Bollinger; Bryan E Hoffman; Daniel J Pelchovitz; Jisheng Yang; Rosanna C Mirabile; Christine L Webb; LeFeng Zhang; Ping Zhang; Michael H Gelb; Max C Walker; Andrew Zalewski; Colin H Macphee
Journal:  Nat Med       Date:  2008-09-21       Impact factor: 53.440

Review 3.  Calcific aortic valve stenosis: methods, models, and mechanisms.

Authors:  Jordan D Miller; Robert M Weiss; Donald D Heistad
Journal:  Circ Res       Date:  2011-05-27       Impact factor: 17.367

4.  Darapladib for preventing ischemic events in stable coronary heart disease.

Authors:  Harvey D White; Claes Held; Ralph Stewart; Elizabeth Tarka; Rebekkah Brown; Richard Y Davies; Andrzej Budaj; Robert A Harrington; P Gabriel Steg; Diego Ardissino; Paul W Armstrong; Alvaro Avezum; Philip E Aylward; Alfonso Bryce; Hong Chen; Ming-Fong Chen; Ramon Corbalan; Anthony J Dalby; Nicolas Danchin; Robbert J De Winter; Stefan Denchev; Rafael Diaz; Moses Elisaf; Marcus D Flather; Assen R Goudev; Christopher B Granger; Liliana Grinfeld; Judith S Hochman; Steen Husted; Hyo-Soo Kim; Wolfgang Koenig; Ales Linhart; Eva Lonn; José López-Sendón; Athanasios J Manolis; Emile R Mohler; José C Nicolau; Prem Pais; Alexander Parkhomenko; Terje R Pedersen; Daniel Pella; Marco A Ramos-Corrales; Mikhail Ruda; Mátyás Sereg; Saulat Siddique; Peter Sinnaeve; Peter Smith; Piyamitr Sritara; Henk P Swart; Rody G Sy; Tamio Teramoto; Hung-Fat Tse; David Watson; W Douglas Weaver; Robert Weiss; Margus Viigimaa; Dragos Vinereanu; Junren Zhu; Christopher P Cannon; Lars Wallentin
Journal:  N Engl J Med       Date:  2014-03-30       Impact factor: 91.245

5.  Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group.

Authors:  C J Packard; D S O'Reilly; M J Caslake; A D McMahon; I Ford; J Cooney; C H Macphee; K E Suckling; M Krishna; F E Wilkinson; A Rumley; G D Lowe
Journal:  N Engl J Med       Date:  2000-10-19       Impact factor: 91.245

6.  Impact of plasma Lp-PLA2 activity on the progression of aortic stenosis: the PROGRESSA study.

Authors:  Romain Capoulade; Ablajan Mahmut; Lionel Tastet; Marie Arsenault; Élisabeth Bédard; Jean G Dumesnil; Jean-Pierre Després; Éric Larose; Benoit J Arsenault; Yohan Bossé; Patrick Mathieu; Philippe Pibarot
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-01

7.  Pioglitazone attenuates valvular calcification induced by hypercholesterolemia.

Authors:  Yi Chu; Donald D Lund; Robert M Weiss; Robert M Brooks; Hardik Doshi; Georges P Hajj; Curt D Sigmund; Donald D Heistad
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-01-03       Impact factor: 8.311

8.  Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial.

Authors:  Michelle L O'Donoghue; Eugene Braunwald; Harvey D White; Dylan P Steen; Mary Ann Lukas; Elizabeth Tarka; P Gabriel Steg; Judith S Hochman; Christoph Bode; Aldo P Maggioni; KyungAh Im; Jennifer B Shannon; Richard Y Davies; Sabina A Murphy; Sharon E Crugnale; Stephen D Wiviott; Marc P Bonaca; David F Watson; W Douglas Weaver; Patrick W Serruys; Christopher P Cannon; Dylan L Steen
Journal:  JAMA       Date:  2014-09-10       Impact factor: 56.272

9.  New therapeutic targets for calcific aortic valve stenosis: the lipoprotein(a)-lipoprotein-associated phospholipase A2-oxidized phospholipid axis.

Authors:  Ming-Yow Hung; Joseph L Witztum; Sotirios Tsimikas
Journal:  J Am Coll Cardiol       Date:  2013-10-23       Impact factor: 24.094

10.  Varespladib and cardiovascular events in patients with an acute coronary syndrome: the VISTA-16 randomized clinical trial.

Authors:  Stephen J Nicholls; John J P Kastelein; Gregory G Schwartz; Dianna Bash; Robert S Rosenson; Matthew A Cavender; Danielle M Brennan; Wolfgang Koenig; J Wouter Jukema; Vijay Nambi; R Scott Wright; Venu Menon; A Michael Lincoff; Steven E Nissen
Journal:  JAMA       Date:  2014-01-15       Impact factor: 56.272
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.